Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marrow transplantation in preleukemia.

H J Deeg

    Journal of the National Cancer Institute
    |June 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Hematopoietic stem cell transplantation offers a promising treatment for preleukemia. This study shows that conditioning with cyclophosphamide and total-body irradiation followed by marrow transplantation leads to long-term disease-free survival in most patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A resonant sextuplet of sub-Neptunes transiting the bright star HD 110067.

    Nature·2023
    Same author

    Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?

    Vox sanguinis·2015
    Same author

    Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients.

    Bone marrow transplantation·2015
    Same author

    Chimeras - no longer a myth.

    Immunology today·2014
    Same author

    Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.

    Bone marrow transplantation·2014
    Same author

    Effect of intravenous coadministration of human stroma cell lines on engraftment of long-term repopulating clonal myelodysplastic syndrome cells in immunodeficient mice.

    Blood cancer journal·2013
    Same journal

    Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

    Journal of the National Cancer Institute·2026
    Same journal

    Beyond R2: Assessing quality of trial level surrogate endpoints in colorectal cancer.

    Journal of the National Cancer Institute·2026
    Same journal

    A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study.

    Journal of the National Cancer Institute·2026
    Same journal

    Response to Yu, Wang and Ge.

    Journal of the National Cancer Institute·2026
    Same journal

    Re: Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

    Journal of the National Cancer Institute·2026
    Same journal

    Welcome reduction of US cervical cancer rates despite state differences.

    Journal of the National Cancer Institute·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Stem Cell Transplantation

    Background:

    • Preleukemia has historically been managed with palliative care.
    • Low-dose cytarabine infusions show limited, short-term responses in some preleukemia patients.

    Purpose of the Study:

    • To evaluate the efficacy of hematopoietic stem cell transplantation as a therapeutic alternative for preleukemia.

    Main Methods:

    • Twelve preleukemia patients underwent allogeneic hematopoietic stem cell transplantation.
    • Conditioning regimens included cyclophosphamide (CY) alone (3 patients) or CY with total-body irradiation (9 patients).
    • Patient outcomes were monitored for at least 1 year post-transplant.

    Main Results:

    • Patients conditioned with CY alone experienced disease recurrence or persistence.

    Related Experiment Videos

  • Nine patients conditioned with CY and total-body irradiation achieved sustained engraftment.
  • Seven of these nine patients remain disease-free 16-36 months post-transplantation.

    • Conclusions:

    • Hematopoietic stem cell transplantation, particularly with cyclophosphamide and total-body irradiation conditioning, offers a potentially curative treatment for preleukemia.
    • This approach provides a viable alternative to palliative measures for preleukemia.
    • Marrow transplantation demonstrates significant long-term survival benefits for preleukemia patients.